Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension the PEGASE study

Hypertension

Volumn 34, Issue 1, 1999, Pages 15-17

  Brand, Eva ^a   Bankir, Lise ^b   Plouin, Pierre François ^c   Soubrier, Florent ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

Blood pressure; Genetic; Genotype; Linkage; Oligonucleotide; Polymerase chain reaction

Indexed keywords

GLUCAGON RECEPTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0032765688     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.1.15     Document Type: Article

References (15)

1. Ahloulay M, Dechaux M, Hassler C, Bouby N, Bankir L. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest. 1996;98:2251-2258.
2. Bankir L, Martin H, Dechaux M, Ahloulay M. Plasma cAMP: a hepatorenal link influencing proximal reabsorption and renal hemodynamics? Kidney Int Suppl. 1997;59:550-556.
3. Laburthe M, Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1. and other members of their new family of G protein-linked receptors: structure-function relationship with special reference to the human VIP-1 receptor. Ann N Y Acad Sci. 1996;805:94-109.
4. Hansen LH, Abrahamsen N, Hager J, Jelinek L, Kindsvogel W, Froguel P, Nishimura E. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes. 1996;45:725-730.
5. Tonolo G, Melis MG, Ciccarese M, Secchi G, Atzeni MM, Maioli M, Pala G, Massidda A, Manai M, Pilosu RM, Li LS, Luthman H. Physiological and genetic characterization of the Gly40Ser mutation in the glucagon receptor gene in the Sardinian population: the Sardinian Diabetes Genetic Study Group. Diabetologia. 1997;40:89-94.
6. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nature Genet. 1996;12:122. Letter.
7. Fujisawa T, Ikegami H, Babaya N, Ogihara T. Gly40Ser mutation of glucagon receptor gene and essential hypertension in Japanese. Hypertension. 1996;28:1100. Abstract.
8. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, Tichet J, Mallet C, Poirier O, Plouin PF, Cambien F. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study: Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens. 1998;16:37-44.
9. Morris BJ, Jeyasingam CL, Zhang W, Curtain RP, Griffiths LR. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects. Hypertension. 1997;30:1640-1641.
10. Morris BJ, Zee RY, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest. 1994;94:1085-1089.
11. Bakris G, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Role of vasopressin in essential hypertension: racial differences. J Hypertens. 1997;15:545-550.
12. Share L, Crofton JT, Ouchi Y. Vasopressin: sexual dimorphism in secretion, cardiovascular actions and hypertension. Am J Med Sci. 1988; 295:314-319.
13. Wang YX, Edwards RM, Nambi P, Stack EJ, Pullen M, Share L, Crofton JT, Brooks DP. Sex difference in the antidiuretic activity of vasopressin in the rat. Am J Physiol. 1993;265:R1284-R1290.
14. Choukroun G, Schmitt F, Martinez F, Drucke TB, Bankir L. Low urine flow reduces the capacity to excrete a sodium load in humans. Am J Physiol. 1997;273:R1726-R1733.
15. + channels in the cortical collecting duct by AVP and mineralocorticoids. Kidney Int. 1992;41: 255-268.